Skip to main content
U.S.

HPV Infections may impact male fertility, study finds

Share

For years scientists have suspected human papillomavirus (HPV) could play a role in male infertility. Now, they’re getting closer to an answer.

Media Landscape

See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this data
Left 20% Center 80% Right 0%
Bias Distribution Powered by Ground News

Until recently, most research about HPV and infertility has been done on women. However, a new study shows certain strains of HPV do appear to play a role in male infertility.

Researchers found “high-risk” HPV strains are more common and can impact sperm quality. Those that are considered high risk are strains that have been linked to cancer.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

The study found high-risk HPV appears to suppress key components of the immune system in the male genital tract. That could harm the body’s ability to clear HPV while also raising the risk of other infections that may also impact male fertility.

A review of 50 different studies done in 2020 found 21% of infertile men had HPV-positive semen. That study also found that even after accounting for female infertility, men with HPV in their semen had a three times greater chance of being infertile than those without the virus.

There are more than 200 known strains of HPV. A vaccine for it has been available since 2006 and the CDC recommends all boys and girls get it at 11 or 12 years old. The vaccine helps prevent nine of the riskiest HPV strains.

According to the CDC, people can still get the vaccine even if they’re older, though it’s usually not as helpful since many people get at least one form of HPV after becoming sexually active. Still, people up to 45 can discuss getting vaccinated with their doctors.

Tags: , , , , , , , , , , ,

[KARAH RUCKER]

FOR YEARS – SCIENTISTS HAVE SUSPECTED HUMAN PAPILLOMAVIRUS, OR H-P-V COULD PLAY A ROLE IN MALE INFERTILITY. 

NOW – THEY’RE GETTING CLOSER TO AN ANSWER. 

UNTIL NOW – MOST RESEARCH ABOUT H-P-V AND INFERTILITY HAS BEEN DONE ON WOMEN.

A NEW STUDY SHOWS CERTAIN STRAINS OF H-P-V *DO* APPEAR TO PLAY A ROLE IN MALE INFERTILITY.

RESEARCHERS FOUND WHAT SO-CALL “HIGH RISK” H-P-V STRAINS ARE MORE COMMON – AND CAN IMPACT SPERM QUALITY. 

THOSE THAT ARE CONSIDERED HIGH RISK ARE STRAINS THAT HAVE BEEN LINKED TO CANCER. 

THE STUDY FOUND HIGH-RISK H-P-V APPEARS TO SUPPRESS KEY COMPONENTS OF THE IMMUNE SYSTEM IN THE MALE GENITAL TRACT… WHICH COULD HARM THE BODY’S ABILITY TO CLEAR H-P-V – WHILE ALSO RAISING THE RISK OF *OTHER* INFECTIONS THAT MAY ALSO IMPACT MALE FERTILITY. 

A REVIEW OF 50 DIFFERENT STUDIES DONE IN 20-20 FOUND 21 PERCENT OF INFERTILE MEN HAD H-P-V-POSITIVE SEMEN.

THAT STUDY ALSO FOUND THAT EVEN AFTER ACCOUNTING FOR FEMALE INFERTILITY – MEN WITH H-P-V IN THEIR SEMEN HAD A THREE TIMES GREATER CHANCE OF BEING INFERTILE THAN THOSE WITHOUT THE VIRUS.

THERE ARE MORE THAN 200 KNOWN STRAINS OF H-P-V.

A VACCINE FOR IT HAS BEEN AVAILABLE SINCE 2006 – AND THE C-D-C RECOMMENDS ALL BOY AND GIRLS GET IT AT 11 OR 12 YEARS OLD.

THE VACCINE HELPS PREVENT *NINE* OF THE RISKIEST H-P-V STRAINS.

THE C-D-C SAYS YOU *CAN* STILL GET THE VACCINE EVEN IF YOU’RE OLDER –  THOUGH IT’S USUALLY NOT AS HELPFUL SINCE MANY PEOPLE GET AT LEAST ONE FORM OF H-P-V AFTER BECOMING SEXUALLY ACTIVE.

STILL, THEY SAY PEOPLE UP TO 45 CAN DISCUSS GETTING VACCINATED WITH THEIR DOCTORS.